NAD+ therapy restores the cellular fuel supply that powers DNA repair (via PARP enzymes), sirtuin activation (the longevity gene pathway), and mitochondrial energy production
Because GLP-1 receptor agonists improve insulin sensitivity and promote weight loss, they have gained attention as adjunct therapy in PCOS management
In terms of documented efficacy, this is not a close comparison: GLP-1 S has shown weight reductions in the range of 13-20% of body weight in clinical trials, while AOD-9604s pivotal trial failed to demonstrate a significant effect at that scale
Huang DQ, Wong VWS, Rinella ME, et al
5 Therefore, people with elevated blood pressure or blood glucose levels should have their kidney function evaluated at least annually